Novartis CEO Says New Purchases Will Boost Sales

April 22 (Bloomberg) -- Novartis AG Chief Executive Officer Joe Jimenez talks about the agreement to buy GlaxoSmithKline Plc’s cancer-drug business for as much as $16 billion, forming a consumer-health venture with Glaxo and selling its animal-health operation to Eli Lilly & Co. for $5.4 billion. He speaks from Basel, Switzerland, with Mark Barton and Anna Edwards on Bloomberg Television's "Countdown." (Source: Bloomberg)

Was the DNC Hack Preventable?
28:43 - Eric O'Neill, Carbon Black's national security strategist, discusses how to respond to government hacks with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • Will Berlin Become Europe's Top Tech Hub?
  • Full Show: Best of Bloomberg Markets Middle East (07/29)
  • Talend CEO: Why We Decided to Go Public Now